Hung D. Le

Array ( [id] => 769259 [patent_doc_number] => 07005412 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-02-28 [patent_title] => 'Method of treating ulcerative colitis and Crohn\'s disease using IL-17 receptor proteins' [patent_app_type] => utility [patent_app_number] => 09/488728 [patent_app_country] => US [patent_app_date] => 2000-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8131 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/005/07005412.pdf [firstpage_image] =>[orig_patent_app_number] => 09488728 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6865529 [patent_doc_number] => 20030191055 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-09 [patent_title] => 'Inhibiting development of microvessels withins coronary or peripheral vessel walls for restenosis/atherosclerosis prevention or therapy' [patent_app_type] => new [patent_app_number] => 09/478621 [patent_app_country] => US [patent_app_date] => 2000-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9921 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20030191055.pdf [firstpage_image] =>[orig_patent_app_number] => 09478621 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 782661 [patent_doc_number] => 06991908 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-01-31 [patent_title] => 'Antiobestic agents methods for screening antiobestic agents and kits comprising same' [patent_app_type] => utility [patent_app_number] => 09/869540 [patent_app_country] => US [patent_app_date] => 1999-12-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 31805 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/991/06991908.pdf [firstpage_image] =>[orig_patent_app_number] => 09869540 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1395622 [patent_doc_number] => 06534063 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-03-18 [patent_title] => 'Methods for treating pervasive development disorders' [patent_app_type] => B1 [patent_app_number] => 09/466559 [patent_app_country] => US [patent_app_date] => 1999-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 4610 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/534/06534063.pdf [firstpage_image] =>[orig_patent_app_number] => 09466559 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1602494 [patent_doc_number] => 06432673 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-13 [patent_title] => 'Growth factor homolog ZVEGF3' [patent_app_type] => B1 [patent_app_number] => 09/457066 [patent_app_country] => US [patent_app_date] => 1999-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 46243 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/432/06432673.pdf [firstpage_image] =>[orig_patent_app_number] => 09457066 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 714485 [patent_doc_number] => 07052685 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-05-30 [patent_title] => 'Methods for treatment of cutaneous T-cell lymphoma' [patent_app_type] => utility [patent_app_number] => 09/419328 [patent_app_country] => US [patent_app_date] => 1999-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2652 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/052/07052685.pdf [firstpage_image] =>[orig_patent_app_number] => 09419328 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1528700 [patent_doc_number] => 06479632 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-11-12 [patent_title] => 'Tumor necrosis factor inhibitory protein and its purification' [patent_app_type] => B1 [patent_app_number] => 09/414609 [patent_app_country] => US [patent_app_date] => 1999-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 8 [patent_no_of_words] => 8797 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/479/06479632.pdf [firstpage_image] =>[orig_patent_app_number] => 09414609 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 62957 [patent_doc_number] => 07758853 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-07-20 [patent_title] => 'IFN-γ production inducing protein (IGIF, IL-18)' [patent_app_type] => utility [patent_app_number] => 09/373230 [patent_app_country] => US [patent_app_date] => 1999-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 15151 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 157 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/758/07758853.pdf [firstpage_image] =>[orig_patent_app_number] => 09373230 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 710477 [patent_doc_number] => 07056734 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-06-06 [patent_title] => 'Differentiation of non-insulin producing cells into insulin producing cells by GLP-1 or exendin-4 and uses thereof' [patent_app_type] => utility [patent_app_number] => 09/762538 [patent_app_country] => US [patent_app_date] => 1999-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 45 [patent_no_of_words] => 23037 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/056/07056734.pdf [firstpage_image] =>[orig_patent_app_number] => 09762538 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 736706 [patent_doc_number] => 07033780 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-04-25 [patent_title] => 'Nucleic acids corresponding to TANGO 294 a gene encoding a lipase—like protein' [patent_app_type] => utility [patent_app_number] => 09/333159 [patent_app_country] => US [patent_app_date] => 1999-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 95 [patent_figures_cnt] => 100 [patent_no_of_words] => 46293 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/033/07033780.pdf [firstpage_image] =>[orig_patent_app_number] => 09333159 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6765648 [patent_doc_number] => 20030100048 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-29 [patent_title] => 'T1 RECEPTOR-LIKE LIGAND II POLYPEPTIDES' [patent_app_type] => new [patent_app_number] => 09/317641 [patent_app_country] => US [patent_app_date] => 1999-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 25890 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0100/20030100048.pdf [firstpage_image] =>[orig_patent_app_number] => 09317641 [rel_patent_id] =>[rel_patent_doc_number] =>)